Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Veterinary Therapeutics Market – Kingdom of Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

Table of Content

Chapter 1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. KSA Veterinary Therapeutics: Market Snapshot
3.2. Market Share Analysis by Region, 2016

Chapter 4. Market Overview
4.1. Product Overview
4.2. KSA Veterinary Therapeutics Market : Market Indicators

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
       5.2.1. Increased meat consumption and  demand for high quality proteins
       5.2.2. Government support for animal feed import  
       5.2.3. Easy availability of antibiotics 
       5.2.4. Current livestock disease outbreaks fueling feed additive usage
       5.2.5. Increase in ownership of companion animals
5.3. Restrains
       5.3.1. Low R&D returns
       5.3.2. Ban on antibiotics due to its harmful effects
5.4. Opportunities
       5.4.1. Growing awareness and affordability of therapeutics for pets and livestock offer significant opportunities to new entrants
       5.4.2. Increasing price of feed products can result in higher demand for feed additives
5.5. Key Trends
       5.5.1. Import of feed additives and meat
       5.5.2. Saudi Arabia\'s broiler production to expand

Chapter 6. Market Outlook
6.1. KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2015–2025
6.2. KSA Veterinary Therapeutics Market Outlook, By Product & Animal
6.3. KSA Government Regulations for Veterinary Products
6.4. Saudi Arabia - Market Entry Strategy
6.5. KSA Veterinary Therapeutics Market: Imports & Local Production Overview
6.6. Value Chain Analysis

Chapter 7. KSA Veterinary Therapeutics Market Analysis, by Pharmaceuticals Product Type
7.1. Introduction
7.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Pharmaceuticals Product Type
7.3. KSA Veterinary Therapeutics Market Forecast, by Pharmaceuticals Product Type
       7.3.1. Ectoparasiticides
       7.3.2. Endoparasiticides
       7.3.3. Antibiotics
       7.3.4. Anti-inflammatories
       7.3.5. Endectocides
7.4. Porter’s Five Forces Analysis

Chapter 8. KSA Veterinary Therapeutics Market Analysis, by Vaccines Product Type
8.1. Introduction
8.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Vaccines Product Type
8.3. KSA Veterinary Therapeutics Market Forecast, by Vaccines Product Type
       8.3.1. Bacterial Vaccines
       8.3.2. Viral Vaccines
8.4. Porter’s Five Forces Analysis

Chapter 9. KSA Veterinary Therapeutics Market Analysis, by Nutritional Feed Additives Product Type
9.1. Introduction
9.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Nutritional Feed Additives Product Type
9.3. KSA Veterinary Therapeutics Market Forecast, by Nutritional Feed Additives Product Type
       9.3.1. Amino Acids
       9.3.2. Vitamins
       9.3.3. Minerals
9.4. Porter’s Five Forces Analysis

Chapter 10. KSA Veterinary Therapeutics Market Analysis, by Disinfectants Product Type
10.1. Introduction
10.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Disinfectants Product Type
10.3. KSA Veterinary Therapeutics Market Forecast, by Disinfectants Product Type
       10.3.1. Floor Disinfectants
       10.3.2. Disinfectants Used in Tissues
10.4. Porter’s Five Forces Analysis
10.5. KSA Veterinary Therapeutics Market Attractiveness Analysis, by Product Type

Chapter 11. KSA Veterinary Therapeutics Market Analysis, by Companion Animal Type
11.1. Introduction
11.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Companion Animal Type
11.3. KSA Veterinary Therapeutics Market Forecast, by Companion Animal Type
       11.3.1. Cats
       11.3.2. Dogs

Chapter 12. KSA Veterinary Therapeutics Market Analysis, by Livestock Animal Type
12.1. Introduction
12.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Livestock Animal Type
12.3. KSA Veterinary Therapeutics Market Forecast, by Livestock Animal Type
12.4. KSA Veterinary Therapeutics Market Attractiveness Analysis, by Animal
       12.4.1. Cattle 
       12.4.2. Sheep
       12.4.3. Poultry

Chapter 13. Company Profiles
13.1. Global Veterinary Therapeutics Market Share Analysis, by Company
13.2. KSA Veterinary Therapeutics Market Share Analysis, by Company
13.3. Competition Matrix
13.4. Company profiles
       13.4.1. Bayer AG 
                 13.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.1.2. Financial Overview
                 13.4.1.3. Product Portfolio
                 13.4.1.4. SWOT Analysis
                 13.4.1.5. Strategic Overview
       13.4.2. Boehringer Ingelheim GmbH 
                 13.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.2.2. Financial Overview
                 13.4.2.3. Product Portfolio
                 13.4.2.4. SWOT Analysis
                 13.4.2.5. Strategic Overview
       13.4.3. Ceva Santé Animale 
                 13.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.3.2. Financial Overview
                 13.4.3.3. Product Portfolio
                 13.4.3.4. SWOT Analysis
                 13.4.3.5. Strategic Overview
       13.4.4. Dechra Pharmaceuticals plc 
                 13.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.4.2. Financial Overview
                 13.4.4.3. Product Portfolio
                 13.4.4.4. SWOT Analysis
                 13.4.4.5. Strategic Overview
       13.4.5. Eli Lilly and Company (Elanco Animal Health) 
                 13.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.5.2. Financial Overview
                 13.4.5.3. Product Portfolio
                 13.4.5.4. SWOT Analysis
                 13.4.5.5. Strategic Overview
       13.4.6. Merck Animal Health 
                 13.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.6.2. Financial Overview
                 13.4.6.3. Product Portfolio
                 13.4.6.4. SWOT Analysis
                 13.4.6.5. Strategic Overview
       13.4.7. Virbac
                 13.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.7.2. Financial Overview
                 13.4.7.3. Product Portfolio
                 13.4.7.4. SWOT Analysis
                 13.4.7.5. Strategic Overview
       13.4.8. Vetoquinol S.A. 
                 13.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.8.2. Financial Overview
                 13.4.8.3. Product Portfolio
                 13.4.8.4. SWOT Analysis
                 13.4.8.5. Strategic Overview
       13.4.9. Zoetis, Inc. 
                 13.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.4.9.2. Financial Overview
                 13.4.9.3. Product Portfolio
                 13.4.9.4. SWOT Analysis

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote